Access to Medicines - Innovative Affordability Programs | Takeda Pharmaceuticals
Innovative Affordability Programs
Despite rising incomes around the developing world, affordability remains a significant barrier to accessing innovative medicines, with out-of-pocket expenses often so high that lifesaving medicines are out of reach.
Takeda has several innovative approaches to address the affordability challenge, including tiered pricing, which allows for price adjustments relative to a country’s income levels and other factors as well as value-based pricing, which responds to payers’ and providers’ needs to manage uncertainty.
In addition, sometimes a more individual approach is required to address affordability barrier. This is the guiding principle driving our affordability-based Patient Assistance Programs (PAPs), which provide tailored affordability support based on patients’ unique financial circumstances.
Discover more about our innovative affordability programs, which are bridging the gap to more equitable and sustainable access in low- and middle-income countries and in countries with evolving healthcare systems.
Bridging Affordability Gaps for Access to Life-Transforming Cancer Treatments in Vietnam
Working hand in hand with the Vietnamese Ministry of Health and our dedicated implementation partners, Takeda’s Patient Assistance Program in Vietnam offers tailored financial support to cancer patients who would otherwise be unable to afford crucial treatment.
A sustainable approach to bridging the affordability gap to life-saving treatments in Mexico
Our Patient Assistance Program in Mexico, launched in 2017, was able to bridge a critical affordability gap, ensuring that patients were able to access full courses of treatment that they would otherwise not have been able to afford.
